Fennec Pharmaceuticals, Inc. (FRX.TO)
13.67
-0.04
(-0.29%)
CAD |
TSX |
May 29, 16:00
Fennec Pharmaceuticals Shareholders Equity (Quarterly) : 52.58M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Bright Minds Biosciences, Inc. | 308.53M |
| Spectral Medical, Inc. | -70.77M |
| Resverlogix Corp. | -125.95M |
| Theratechnologies, Inc. | -38.39M |
| COSCIENS Biopharma, Inc. | 21.38M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 100.23M |
| Total Liabilities (Quarterly) | 47.65M |
| Current Ratio | 6.977 |
| Net Debt Paydown Yield | 1.81% |